Psychedelic drug
Drug typeWikipedia
73
MENTIONS
40
EPISODES
38
PODCASTS
Search complete. 73 mentions across 40 episodes found for "Psychedelic drug".
Oct 27, 2026
Bonus Episode: Psychedelic Research Inside an Academic Medical Center with Scott Thompson, PhD
B
7:42Ben EverettHOST
All right, but before we really dive in, I just want to orient a quick note for our listeners.
B
7:47Ben EverettHOST
So this episode actually completes a two-part conversation that began a few weeks ago with Dr. Stephen Berkowitz, and he suggested Dr. Thompson might be a better person to take us deeper into CU's psychedelic research program.
B
8:00Ben EverettHOST
So with that, let's really – I want to talk about the CU program because I think it is really – a foundational example of what I think psychedelic research programs should look like.
B
8:13Ben EverettHOST
It's multidisciplinary.
B
8:14Ben EverettHOST
You've got from different backgrounds, from different specialties, all coming together at looking at psychedelics.
B
8:20Ben EverettHOST
So maybe if we can start with a 30,000 foot view, you direct the novel therapeutics within CU's Brain and Behavior Innovation Center.
B
8:28Ben EverettHOST
So can you orient our listeners to what's happening in psychedelic research within your department and then the psychedelic research consortium more broadly?
S
8:38Scott ThompsonGUEST
Yes.
Nate Rose #101
N
32:19Nate RoseGUEST
Philosophy took me to a place.
N
32:20Nate RoseGUEST
Psychedelics took me to a place.
N
32:23Nate RoseGUEST
My friends, great conversation with my friends took me to places.
N
32:26Nate RoseGUEST
Yeah.
Chapter 166: Ethan Kross invites insight by interrupting internal interference
E
32:30Ethan KrossGUEST
So you can get that kind of expansion from the world around us.
E
32:36Ethan KrossGUEST
Psychedelics are, anecdotally, I've spoken to a lot of people who have benefited, report benefiting quite a bit from them.
E
32:46Ethan KrossGUEST
The experience has been is that it does blur this, like you become merged with something the energy around you.
E
32:54Ethan KrossGUEST
And it also puts you in a state of mind that allows some individuals to reframe things more effectively, find insight into their experiences.
The Case Against Being Nice
H
29:39Holly WainwrightHOST
But the thing about this interview is it's not really about that because the reason that Judith Lucy was on the press trail at all when she got her cancer diagnosis, is that she's written a memoir, a book called Well, Well, Well, and it's all about wellness.
H
29:52Holly WainwrightHOST
And the tagline for it is My Wellness Odyssey from Psychics to Psychedelics and Beyond.
H
29:59Holly WainwrightHOST
So she says that after COVID and various things, she got really burnt out.
H
30:02Holly WainwrightHOST
And she said as a Gen X woman, she didn't believe in burnout, which is very typical.
The Programmable Human
J
9:13Joseph L. FlatleyHOST
The magazine was called High Frontiers.
J
9:16Joseph L. FlatleyHOST
The full subtitle reads, The Space Age Magazine of Psychedelics, Science, Human Potential, Irreverence, and Modern Art.
J
9:26Joseph L. FlatleyHOST
The first issue was published in 1984 on the cheapest paper available.
J
9:33Joseph L. FlatleyHOST
High Frontiers issue number one ran interviews with Timothy Leary and Albert Hoffman, who discovered LSD.
How “Burning Man” is Shaping the World (with Alex Newman)
A
47:02Alex NewmanGUEST
There's witches, there's sorcery, there's blatant attacks on Christianity.
A
47:07Alex NewmanGUEST
One of the talks we went to was by the high priest of the Church of Psychedelics.
A
47:11Alex NewmanGUEST
And interesting guy.
A
47:12Alex NewmanGUEST
He's got about 150,000 members of his so-called church.
Episode 64 - Our Bestie Lore
J
28:27JenHOST
Obviously you guys were the weed school, but there was also a lot, a lot of like shrooms and like people in trees dropping acid and like,
N
28:37NatalieHOST
Psychedelics.
N
28:38NatalieHOST
Yeah.
N
28:38NatalieHOST
You went more hard drugs.
Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing
J
0:05Josh HardmanHOST
Welcome to the Psychedelic News Feed, a podcast from Psychedelic Alpha.
J
0:09Josh HardmanHOST
Each episode brings you up to speed with the latest across psychedelic drug development, policy, and access from around the world.
J
0:16Josh HardmanHOST
It's presented by me, Josh Hardman, Psychedelic Alpha's founder and editor.
J
0:21Josh HardmanHOST
These are intended to be concise summaries as opposed to deep dives.
J
0:25Josh HardmanHOST
If you are looking for more nuanced analysis, exclusive interviews, and unrivaled reporting on these topics and much more, head to psychedelicalpha.com.
J
0:43Josh HardmanHOST
Welcome to the third episode of the Psychedelic News Feed podcast, this episode covering October 5th to 18th, 2026.
J
0:52Josh HardmanHOST
We have five main stories to run through today and then some additional headlines.
J
0:56Josh HardmanHOST
The first is some early notes from the Psychedelic Healthcare Forum that we hosted last week in New York City.
The Truth Behind the Psychedelic Revolution | John O'Connor
J
14:21John O'ConnorGUEST
It just means, you know, the cops aren't going to break down your door looking for your stash of LSD.
J
14:28John O'ConnorGUEST
You know, but so I do think, you know, I think we are... are headed to a saner more sober if you will landscape with these with these drugs but it's i don't think it's gonna go quite how cannabis went really quickly um well it was a long it took a long time to get to um to the legislation but once we got there it went state by state and now we have over half states have full legalization with many more kind of decriminalized cannabis use and um Psychedelics will probably follow not exactly the same path, but a similar one.
J
15:05John O'ConnorGUEST
In April, President Trump fast-tracked psilocybin and other kinds of psychedelics.
J
15:15John O'ConnorGUEST
I think I will gain MDMA, fast-tracked them for FDA approval, specifically to treat PTSD.
Associate Professor Vanessa Beesley: Grief, Psychedelic Therapy and Finding Meaning After Loss
E
1:09Esme DarkHOST
This episode, we are speaking with Associate Professor Vanessa Beesley.
E
1:15Esme DarkHOST
She is a Distinguished Behavioural Scientist and a Team Head of the Psychedelic Medicine and Supportive Care Group at the QIMR Medical Research Institute.
E
1:27Esme DarkHOST
She leads the Psilocybin-Assisted Supportive Therapy trial, which looks at the treatment of prolonged grief disorder, and she is the Chief Investigator on a number of other trials.
E
1:41Esme DarkHOST
She has a career spanning two decades in psychopharmacology and is committed to person-centred care, addressing supportive care needs for patients and their caregivers.
E
4:44Esme DarkHOST
Is that right?
V
4:46Vanessa BeesleyGUEST
Yes.
V
4:46Vanessa BeesleyGUEST
I'm a behavioural scientist and I am the team head of the Psychedelic Medicine and Supportive Care Group at QRMR Berghofer.
V
4:55Vanessa BeesleyGUEST
which is a world-leading medical research institute up in Brisbane.
30 more episodes mention Psychedelic drug.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.